‘No Time to Die’ delayed yet again, this time until October
Securing a firm release date for the latest James Bond film is trickier than pinning down the fictional superspy himself.
For at least the fourth time, “No Time to Die,” Daniel Craig’s fifth and final foray as Bond, has been delayed, Variety reported on Thursday.
The eagerly anticipated blockbuster was originally slated to drop in November 2019 but was stymied by would-be director Danny Boyle bowing out. The film was then expected to hit cineplexes in April 2020 but was halted due to the ongoing COVID-19 outbreak.
Now, its April 2 release date has been pushed back by more than six months to Oct. 8.
“Those who have their eye on the long game understand that for a film like Bond, and many others, the prestige, exclusivity and revenue-generating potential of the movie theater is still undeniable and still worth waiting for,” Comscore media analyst Paul Dergarabedian explained to CNBC.
“No Time to Die,” which cost upwards of $250 million to produce, has already reportedly lost tens of millions in marketing and promotion.
The film, which co-stars Oscar winners Christoph Waltz and Rami Malek, will be the last to feature Craig as the classic Ian Fleming character.
Arnold Schwarzenegger pays homage to 2 of his films while receiving COVID inoculation
The previous Bond film, “Spectre,” raked in a whopping $880 million worldwide following its 2015 release, noted Box Office Mojo. But that sum was nearly a quarter of a billion dollars less than its predecessor “Skyfall,” according to reports.
“No Time to Die” is by no means the lone major feature cooling its heels. The live-action musical adaptation of “Cinderella,” “Ghostbusters: Afterlife” — reuniting Bill Murray, Dan Aykroyd and Ernie Hudson for a third time — and “Uncharted,” based on the video game of the same name, have also been delayed, CNBC reported.
